Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Nichi-Iko Pharmaceutical Co Ltd (Nichi-Iko) is a pharmaceutical company. Its primary activities include the manufacturing, sales, distribution, export, and import of various types of pharmaceuticals. The company's products are generic drugs, that are developed using unique and innovative formulation techniques. Nichi-Iko's products are used to treat conditions related to the circulatory, digestive, respiratory, central and peripheral nervous systems, among others. It also offers medicines in various forms including oral disintegration tablets, chewable tablets, gels, capsules, and powders. The company operates in Hong Kong, Thailand, Malaysia, Vietnam, Philippines, Singapore and Japan. Nichi-Iko is headquartered in Toyama, Japan.
Headquarters
Japan
Address
1-6-21, Sokuruwa, Toyama, 930-8583
Website
www.nichiiko.co.jp
Telephone
81 76 4322121
Industry
Pharmaceuticals and Healthcare
Nichi-Iko Pharmaceutical Co Ltd premium industry data and analytics
Products and Services
| Products |
|---|
| Anti-Platelets |
| Anti-Allergens |
| Anti-Diabetics |
| XYZ |
| XYZ |
| XYZ |
Competitor Comparison
| Key Parameters | Nichi-Iko Pharmaceutical Co Ltd | Towa Pharmaceutical Co Ltd | Dong-A Socio Holdings Co Ltd | Jeil Pharmaceutical Co Ltd | Wakamoto Pharmaceutical Co Ltd |
|---|---|---|---|---|---|
| Headquarters | Japan | Japan | South Korea | South Korea | Japan |
| City | Toyama | Kadoma | Seoul | Seoul | Chuo-Ku |
| State/Province | Toyama | Osaka | - | Seoul | Tokyo |
| No. of Employees | - | 4,588 | 273 | 978 | 303 |
| Entity Type | Private | Public | Public | Public | Public |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Yasuhiro Nagafuku | Chairman | Executive Board | - | - |
| Tetsuya Ono | Senior Executive Officer; Director | Executive Board | - | - |
| Katsuhiko Orito | Director; Senior Executive Officer | Executive Board | - | - |
| Shingo Iwamoto | Chief Executive Officer; President | Senior Management | - | - |
| Susumu Kanda | Managing Director | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer